Loading...
Defining the right diluent for intravenous infusion of therapeutic antibodies
Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...
Na minha lista:
| Udgivet i: | MAbs |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927757/ https://ncbi.nlm.nih.gov/pubmed/31774346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1685814 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|